Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

anti-inhibitor coagulant complex

A sterile, freeze dried fraction of human plasma containing factor VIII coagulant antigen and both the inactive and active forms of coagulation factors II (prothrombin), VII, IX and X, with factor VIII (FVIII) inhibitor bypassing activity. Upon reconstitution and infusion, anti-inhibitor coagulant complex is able to, either directly or indirectly, activate thrombin, which facilitates the formation of fibrin from fibrinogen. This results in clot formation. In hemophilic patients, antibodies formed against factor VIII prevent factor VIII activation and impair thrombin formation; anti-inhibitor coagulant complex can both overcome the inhibitory activity of the antibodies and facilitate hemostasis in hemophilic patients.
Synonym:factor eight inhibitor bypassing activity
Search NCI's Drug Dictionary